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The Brindled variant of the mottled mutant mouse Mo^^ (Hunt et al,,
1974) was used to study the effect of copper therapy on the survival
of the affected male offspring. The male of this sex-linked inherited
(copper malabsorption) disease survives for 14 days postnatally, and is
a model for Menkes kinky hair disease (Menkes et al,, 1962), Parenteral
copper therapy in the human has led to the survival of one human baby
with tremendous neurologic deficits (Gover § Jutton, 1975),
In these experiments, copper fed mothers did not survive after the
copper levels approached or exceeded 100% of normal, Copper fed male
offspring when injected according to a specific time table, have survived
and are now being tested for virility. The copper containing enzymes
tyrosinase, ceruloplasmin, superoxide dismutase and cytochrome oxidase
which were deficient in the untreated male were normalized after treatment
even in the males that did not survive. Although malabsorption of copper
characterizes the disease, the therapeutic time table for reversibility
iii
of the disease process seems quite specific and evasive and must be
addressed in the human disease. It is our hope that the findings
presented here lend some support to the probability of being able to
stop the phenotypic events which accot^jany this dread human disease.
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The malabsorption of copper as a primary cause of Menkes' Kinky
Hair Syndrome was first reported by Danks et al, in 1D72, This disorder
is an X-linked inherited progressive neurological disease that is fatal.
In humans', the disease is characterized by growth retardation, cerebral
degeneration, and abnormal hair referred to as kinky or steely hair.
In 1972, Danks et al. detected a copper deficiency in individuals
with this disease and suggested that this was perhaps due to a malabsorp¬
tion of copper in the intestinal tract. Danks et al, (1973) later
reported that although the uptake of copper into the epithelial cells
from the gut lumen was normal, the transport of copper from the intestinal
mucosal cells into the blood stream was reduced. This finding provided
adequate explanation for the gross copper deficiency that is characteristic
of this disease.
The Brindled variant of the mottled mutant mouse of this sex linked
inherited disease is known to survive for 14 days postnatally, without
any special copper treatment. Since copper deficiency has been shown to
underlie the human X-linked progressive brain disease, and, too, since
the mottled mutant mouse has been shown to have a similar disorder, the
mottled-mouse syndrome was chosen as a model to help elucidate some of




After the detection of copper deficiency in man, early investigators
attempted to raise plasma copper with intravenous copper therapy.
Although successful in raising plasma copper levels to normal, there was
no sustained improvement in the clinical state. Copper was also found to
be toxic when given parenterally and similar results were noted when
copper was administered intramuscularly. The majority of experiments
or reports were concerned with children in which the clinical manifestation
had reached an irreversible stage. But in 1975, Grover and Scrutton on
the advice of Cyril L. Moore, treated an infant, with this syndrome. The
diagnosis was made at the age of 3 days This early diagnosis suggests
that copper storage and/or availability was inadequate during fetal life,
or that there was another undiscovered parameter in this disease. Copper
therapy on this infant was started at the age of 28 days. The fact that
this infant is now six years of age provides evidence to support the
thesis that early copper therapy may be beneficial in the prolongation
of life. It is true, however, that inspite of the increased life span, the
neurologic deficits were only minimally reversed by this therapy, although
the blood copper, caeruloplasmin and cytochrome oxidase levels remain
normalized in the absence of continued copper therapy.
The effect of copper deficiency in the human and mutant mouse has been
shown to be on the copper-requiring enzymes. For example, brain cytochrome
oxidase is affected more than liver or muscle cytochrome oxidase, the
former dropping as low as 10-15% normal while the latter falls to 20-30%.
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There is a substantial drop (%) in the activity of the copper
containing enzyme, tyrosinase. This can explain the virtual absence
of hair pigmentation, since tyrosinase is the first enzyme in the melanin
biosynthetic pathway.
Caeruloplasmimanother copper containing plasma protein, is also
very low or absent. Although the precise function of caeruloplasmin
is still unknown, it is believed that it is a copper transport protein
which may be important to the maintenance of a proper copper distribution.
Another copper requiring enzyme superoxide dismutase (which has a very
important function in the metabolism of the cytologically dangerous
superoxide radical) is absent.
The deficiency in these enzymes can therefore be directly related
to a deficiency in the amount of available copper supply. Intraperitoneal
copper therapy was the method chosen to study the effects of copper
therapy. Subcutaneous injections eventually led to the survival of the
hemizygous offsprings. Although, subcutaneously injected copper did
lead to the survival of the hemizygous males, the extent of survival
was related to the age at time at which copper therapy was initiated
after birth. Biochemical and anatomical studies were carried out in
which hemizygous males (controls), hemizygous males that received copper
therapy, normal males, and normal males that also received the equivalent
copper therapy were compared.
Some copper containing enzymes were evaluated based on their total
activity, enzymes monitored was cytochrome oxidase. This
enzyme is the terminal enzyme of the electron transport chain and is
responsible for the transfer of electrons to oxygen with the possible
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formation of either H2O, OH", or 02" Cthe superoxide radical). If
cytochrome oxidase is defective or dysfunctional death will ensue.
Another enzyme that was measured was caeruloplasmin. This enzyme
is possibly required in maintaining the plasma copper and/or responsible
for the transportation of copper. Siq)eroxide dismutase was the third
enzyme that was evaluated. This enzyme catalyzes the dismutation of
superoxide radicals (02“ • + 02" ' + 2H^ ^ - O2 + H2O2), and is
principally localized within erythrocytes. Superoxide dismutase is
important in controlling the activity of superoxide radicals. The
fourth and final enzyme that was evaluated was tyrosinase, which is a
relatively stable mammalian enzyme. It catalyzes the conversion of
Tyrosine to DOPA and DOPA is subsequently converted to melanin. Without
melanin formation the individual would be or would resemble an albino.
Within these experiments emphasis was placed on copper content of
the blood and enzyme activity. Where appropriate, data are compared
and contrasted between the normal and the diseased animal. The changes
in the physical and clinical manifestations while copper therapy was in
progress is documented with photographs. Throughout this thesis there
are various charts and photographs to further exemplify the changes
that occurred within the research that is presented here.
Purpose of Our Research
If kinky hair disease is to be corrected therapeutically, it is
important that the blood copper levels be elevated by some mechanism
which would preclude intoxication of the subject as is seen in the
copper storage (Wilson's) disease. There are only a few ways in which
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copper can be administered to tKe perinatal animal; these include the
postnatal GI, IV, and IP route, as well as the prenatal transplacental
route. It has been established that none of the postnatal routes is
truly effective in the human disease, but, since the neonatal mouse
resembles the prenatal human, it is possible that the routes of copper
administration in the mouse other than via intestinal absorption might
afford an opportunity to examine the effect of progestational and
gestational therapy on patient recovery in the human disease.
The questions which we have posed include: (1) What is the effect
of copper feeding during the second and third weeks of gestation in the
mouse? (2) How would this feeding be controlled and the copper levels
in the maternal and fetal blood monitored? (3) What effects would
early or late postnatal copper therapy have on the longevity and
neurologic competence of the animal? (4) Is the apparent deficiency
of the copper proteins due to a decrease in the activity of the protein,
due to a decrease in the activity of protein or to a decrease in synthesis
of the apoprotein? Does the presence of systemic copper lead to de novo
synthesis or to incorporation of the copper in a pre-existing enzyme?
These are some of the questions being asked by our laboratory, and
to some of which we have obtained answers and/or clues.
Specifically, we have examined the various feeding modalities, in
teims of their affect on the behavior of the diseased animals as a whole
as well as their effect on the levels of circulating and other extra-




In 1962 John H. Menkes, described a new degenerative disease o£ the
central nervous system, which he believed to be caused by a metabolic
defect (Menkes, 1962), During a twelve year period proceeding the first
publication on Menkes kinky-hair disease (MKHD), Menkes and his colleagues
evaluated 5 boys from a white family of English-Irish decent. All five
boys were affected with mental retardation and failure to thrive, After
twelve years of evaluation Menkes first reported that the disease was
distinguished by a rapidly progressive cerebral degeneration, pili torti,
failure to gain weight, white hair, sex-linked recessive transmission and
death before the age of three. Two of the boys were examined directly by
Menkes and his colleagues. Information on the other three was obtained
from medical records and answers from the family.
In summary of Menkes first report of this disease, he implicated that
the condition described in his paper represented a new clinical syndrome
that was due to an inherited error in metabolism. In the two cases studied
by Menkes, postmortem examination revealed a widespread degeneration of
the cerebral gray matter and secondary degeneration of the cerebral white
matter. He also found a diffuse atrophy of the cerebellar cortex.
Biochemical studies conducted on one of the boys showed that the levels of
glutamic acid were higher than normal.
Four years later Aguilar et al. reported on six case studies (Aguilar,
1966). The six boys studied showed clinical features which were strikingly
6
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similar to those described by Menkes in 1962, Her report was based
mainly on the postmortem studies of the two autopsied cases described,
The results of Menkes were thus confirmed by a second group of investi¬
gators who also described more widespread neuropathological abnormalities.
The head was reported brachycephalic and small, measuring 43 cm in
circumference (average value for a 12 month old male is 47 cm). There
were bitemporal crainiotomy scars. The anterior fontanelle was open,
but small; the bony sutures were partially closed; the skull was
increased in thickness; the dura was thick and myxoid and there were
bilateral subdural membranes over the convexities. The brain weighed
435gm (normal weight 935gm). The cerebrum was small and the folia was
narrow. The coronal sectioning revealed pale firm cortical gray matter
and a decreased amount of white matter with moderate enlargement of the
lateral ventricles. The cerebellar cortex was pale and narrow with an
indistinct corticomedullary margin. The upper and lower brain stem
and the spinal cord showed no gross abnormalities.
The sex-linked recessive pattern of inheritance presented in the
reports of both Menkes and Aguilar, demonstrated and supported well the
idea of the disease being sex-linked recessive. Further evidence of
this disease being sex-linked recessive came from the finding that in
Aguilar's report, two separate males sired two diseased offsprings with
the same mother.
O'Brien and Sampson in 1966 coined the term Kinky Hair disease
(O'Brien, 1966). In these studies they found a reduction in gray matter
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docosahexaenoic acid. This acid is the most highly unsaturated fatty
acid in the brain, O'Brien and Sampson suggested that this disorder
was due to an accumulation within neurons of oxidized lipids which
could disrupt mitochondria and microsomal function. As a result of
these findings they proposed a mechanism for the cause of Kinky Hair
Disease. They proposed that products of oxidized lipids were
accumulating in the involved neurons of the Kinky Hair disease CKHD)
patients. Also that such toxic products were interfering with the
metabolic machinery of such involved cells. Therefore, the profound
neurological changes which occurred in the KHD may be partially explained
by cellular damage or abnormal metabolic function. They also concluded
that there was no reason to postualte a deficiency of antioxidants in
their patients because both of them were receiving supplemental levels
of vitamin E and there was no evidence of malabsorption.
Danks et al. published a paper in 1972 proposing copper to be the
primary cause of the disease (Danks, 1972). They examined seven new
cases of Menkes' Kinky Hair syndrome. After extensive study an evaluation
was made and they found several things that were relevant to Menkes'
syndrome. The first was hypothermia. Hypothermia is a body temperature
lower than normal. They also found low levels of serum copper and
caeruloplasmin. One of the most significant findings made by Menkes was
the discovery of a defect in the intestinal absorption of copper. For
this reason they postulated a copper deficiency due to defective intes¬
tinal absorption of copper as the basic biochemical defect in Menkes'
Syndrome. Furthermore the recognition of seven patients within a
3 year period indicated that this disease may sometimes go
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undiagnosed. All other clinical manifestations prior to this report
were confirmed in Banks* report. Theso findings opened up new avenues
of investigation into the normal mechanism of copper adsorption. After¬
wards, Banks suggested that treatment of this serious disease would soon
be possible.
Also in 1972 (May) Menkes reported hypothermia to be a common
symptom and that pili torti only develops some weeks later after birth
(Banks, 1972), confirming the work by Banks (Banks, 1972). Oral copper
therapy was administered to one patient in the form of CuCl2- The results
showed an initial rise in serum copper levels accompanied by a slight
clinical improvement. The patient’s temperature stabilized between
36.5 and 37 C, As a result he became more active and smiled for the
first time. Subsequently the serum copper levels returned to their
initial very low levels. The clinical improvements were noted. It was
later postulated in the same report that because of earlier tests that
included the injection of 80 pg of copper, the clinical improvements
noted may have been due to the injection of copper rather than the
orally administrated copper.
In a second case where oral copper was the only copper therapy used
the results were not promising. Soon after copper was first administered
the boy started to take solid foods. His growth improved, but there
was no significant change in his neurological state. Later when another
case was reported. Banks tried intravenous copper therapy. Attempted
therapy with intravenous cupric chloride ClOO yg daily) had to be
discontinued when the second dose caused transient peripheral circulatory
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failure, The findings of Danks et al, C1972) appear to establish defective
intestinal absorption of copper and consequent copper deficiency as
consistent features of Menkes^ syndrome. This was demonstrated very
effectively by oral administration of copper-64 to two patients. The
results showed diminished absorption in both patients in comparison with
the control child. The collection of stool was incomplete in one patient,
but 75% of the dose was recovered in 48 hr. In the second case a total
stool collection was made. In a 48 hr period 97% of the copper-64 that
was administered was recovered. Menkes suggested that the slight
improvement noted in the first patient could be promising. But therapy
will have to start from or perhaps before birth to be of greatest benefit
to the patient.
In 1972 French et al. examined the possibility of a defect in anti¬
oxidant metabolism (French, 1972). They noted the virtual absence of
cytochrome a+a3 in brain mitochondria. Cytochrome a+a^ (cytochrome c
oxidase) constitutes the terminal complex of respiratory chain. Cyto¬
chrome oxidase also contains both heme and copper which are essential
for its redox function. This neurodegenerative disease has been reported
in previous papers as Kinky Hair Disease (Aguilar, 1966 and Billings,
1971), and as a Sex-Linked Recessive Disorder with Retardation of Growth,
Peculair Hair, and Focal Cerebral and Cerebellar Degeneration. It has
also been referred to as a Sex-Linked Neurodegenerative Disease Associated
with Monilethrix (Bray, 1965). French et al, suggest that this nomen¬
clature is inappropriate. The first one is inaccurate because the
abnormalities are not present in physiologically kinky hair. The second
one is not only too cubersome as is the third, but it only describes
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one of three hair abnormalities. TKerefore, they suggested that
’’trichopoliodystrophy" most adequately describes this disorder. This
name emphasizes the abnormalities of the hair CGreek Trichos}, The
Greek word Polis means gray matter of the nervous system and the Greek
words Dys plus Trophos means failure to thrive.
In 1973 Danks et al. introduced the term steely-hair to replace
the term Kinky-Hair which accurately describes the appearance of Menkes
syndrome (Danks, 1973). Microscopically there is pili torti of the
hair. Macroscopically the hair is depigmented and lustreless, stands
on end, and becomes tangled. It looks and feels quite like steel wool.
Therefore, they suggested that the name steely-hair should replace the
name Kinky-Hair, since the old term Kinky Hair would cause clinicians
to expect crimpled hair.
Walker et al. in 1973 discussed the therapeutic iii5)licat ions of
copper deficiency in Menkes Steely-Hair syndrome (Walker-Smith, 1973).
In one infant treated, copper EDTA was used as therapy. There was a
rise in plasma copper oxidase, which reflects plasma caeruloplasmin
levels. As a result the state of copper deficiency was relieved. The
rise in plasma copper oxidase levels indicated that the liver could
synthesize caeruloplasmin once copper was available to it. Since the
state of copper is restored once the gut is by-passed, this supports the
view that the defect in Menkes' Steely-Hair syndrome is principally a
malabsorption problem. Unfortunately the neurological sequelae of this
disorder were unaffected. Also the neurological sequelae are unlikely
to be reversed once a state of chronic copper deficiency has developed.
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Low brain copper levels were reported in all 3 children examined.
They suggested the possibility tivat infants with Menkes’ Steely-Hair
syndrome have adequate copper stores at birth, since the clinical
manifestations of the disease do not appear for a few months postnatally,
Since bile constitutes the main excretory pathway for copper in man,
the enterhepatic circulation of copper is small, Actually it comprises
only the low and readily diffusible fraction of biliary copper. The
reduction or abolition in these infants with copper malabsorption would
lead them to becoming copper depleted within a few months after birth.
This interval of time would presumably depend on the size of their
copper stores at birth. However, they do suggest that once the symptoms
appear as they have reported, the onset of convulsion and clinical
deterioration is rapid. It is unlikely that intrauterine diagnosis will
be possible because the infant would be receiving adequate copper from
his mother. They do suggest that when there is a family history of a
death of a child from Menkes' syndrome, sexing in early pregnancy when
the fetus is found to be a male, abortion could be advised, If plasma
copper is estimated serially from birth in children bom into such
families there is a chance that early parental copper therapy might
be successful in preventing cerebral damage. They concluded that intra¬
muscular copper (copper-EDTA) with careful monitoring of plasma copper
levels, offers the best course of treatment at this time.
J, R. Prohaska et al, in 1974 used the developing rat brain as a
possible model for Menkes Steely-Hair disease (Prohaska, 1974). The
similarities between Menkes disease and the copper deficient rat
included slow growth, a slight decrease in whole brain and cerebellar
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growth and a highly significant decrease in myelination based on the
activity of cerebellar-2, 3-cyclic nucleotide 3-phosphohydrolase,a
myelin enriched protein. Specific effects of a five fold reduction in
the copper content of brain were seen in a drastic decrease in
cerebellar cytochrome c oxidase and smaller but significant drops in
cerebellar superoxide diSBiutase and brain norepinephrine concentrations.
They suggest that a decrease in superoxide dismutase in copper deficiency
may have a deleterious effect on neural tissue. This could give rise to
an increase in lipid peroxidation, O'Brien and Sinqjson (1966) reported
a decrease in docosahexaenoic acid content, in phosphatidyl ethanolamine
and phosphatidyl serine and suggested an increase in the peroxidation
of unsaturated lipids in patients with Menkes disease, French et al.
1972 reported a diminution of unsaturated fatty acids in white matter,
and an increase in hydrogen peroxide hemolysis of erythrocytes from a
patient. Superoxide dismutase has been shown to play a role in protecting
erythrocytes against peroxidative hemolysis (Fee § Teitelbaum, 1972).
The role of superoxide in lipid peroxidation has been reported by Pederson
and Aust in 1973.
They all concluded that until further evidence is presented on
reduced brain copper in Menkes disease, the explanation for aberrant
behavior, neuronal damage, increased peroxidation of lipids based on
changes in the copper (metallo) enzymes (siqieroxide dismutase,
cytochrome c oxidase, and dopamine-Beta-hydroxylase) is still speculation.
As Danks in 1972 pointed out, the brain damage may be the result of
arterial disease caused by the derangement of elastin (O’Dell, 1961).
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David M. Danks in 1974 published a summation of all the findings
on Menkes Syndrome. Also included was a short biographic data section
on himself. He stated that he received his medical education and
pediatric training at the University of Melborne. His training in
genetics was received in the Medical Research Council Genetics Research
Unit at the Institute of Child Health in London and The John Hopkins
Hospital, Baltimore, Since 1967, Dr, Danks has Been a reader in Human
Genetics at the University of Melbourne and Medical Geneticist to the
Royal Children's Hospital Research Foundation.
The rest of his summation basically states, the fault in Menkes
syndrome appears to lie in the transport of copper from the intestinal
mucosal cell into the blood stream. Uptake from the intestinal content
into the mucosal cell is probably normal. This defect results in copper
deficiency of a profound degree which is certainly established by the
age of 5 months and can be safely presumed to precede the onset of
symptoms. Excess of free sulphydryl groups has been found in the hair
of this disease (Gillespie, 1964), A decrease in cross-links between
polypeptide chains in elastin is probably due to a decrease in the
enzyme which is responsible for the cross links. Their results showed
this enzyme to be amine oxidase. Amine oxidase is a copper dependent
enzyme which is responsible for the cross-links between polypeptide
chain in elastin (Carnes, 1971).
The bonds are formed between lysine residues. The lesions seen in
the arterial walls are very similar to those described in spontaneous
or induced copper deficiency in domestic and experimental animals. A
decrease in cross-links between polypeptide chains in elastin could
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also be explained by a deficiency of lysyl oxidase, Which is also a
copper containing enzyme. In fact lysyl oxidase was blamed for this
very thing in the paper by Underwood et al.(1971). The depigmentation
of hair is presumably the result of deficient tyrosinase activity.
The results presented in the paper by D. M. Hunt (1974) showed
that a primary defect in copper transport underlies the mottled
syndrome in the mouse. The X-linked mottled mutants thus offer an
excellent system for study of mammalian copper metabolism. Therefore,
they concluded that these animals would make an excellent model for
the inherited human copper deficiency presented here, Menkes Kinky
Hair disease.
A number of different mutant alleles at the mottled locus are
known and these include the Blotchy (Mo^^°), Brindled (Mo^’^), Dappled
(Mo^P), Mottled (Mo), and the Viable-brindled (Mo^^^). In all cases
where the male heraizygote survives beyond birth, the resulting mouse
shows a severe dilution in hair pigment. The individual hair has
altered hair structure and the whiskers are curly. Estimates of liver
and brain copper in 10 day-old brindles revealed a deficiency. There
was an accumulation of copper in the intestinal wall. This indicates
that uptake from the gut lumen is normal but that the general body
deficiency arises from a defective transport within the intestinal
epithelium or mucosal cells or across the membrane on the serosal
aspect of these cells. This interpretation was tested and proven.
The results confirmed that the initial uptake into the intestinal
epithelium is not defective.
Copper levels are depressed in liver and serum and the accumulation
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o£ copper in the intestinal epithelium directly parallels that in the
human disease. The phenotypic variegation arises from random X inactiva¬
tion in female heterozygotes for an X-linked coast color mutant which
depends on the cells autonomy of the mutant defect. Copper deficient
cells would he expected to he at a selective disadvantage in competition
with their normal counterparts CGruneberg, 1969). Thus leading to a
progressive dilution of mutant cells during development. This is
supported hy the progressive darkening of hrindled heterozygotes with
age (Grover, 1975).
Later in 1974 more extensive work was done to detect caeruloplasmin
levels in kinky hair disease patients (Matsuda, 1974), Matsuda et al.
used the radioimmunoassay technique to detect apoceruloplasmin. This
technique can detect as little as lOng of apoceruloplasmin. Their
results revealed that apoceruloplasmin in infants with Menkes Kinky-Hair
(1.4 0.5 mg per 100ml) differed significantly from normal (3.3 ^
3.1mg per lOOmg) infants. These findings suggested that apoceruloplasmin
synthesis does not continue at a normal rate with a reduced availability
of copper. The holoceruloplasmin was virtually undectable. Within 2
weeks after the oral administration of copper in an infant with nutritional
copper deficiency, holoceruloplasmin concentration was increased to 30mg
per 100ml, hut apoceruloplasmin concentration remained unchanged, This
evidence further si:5)ports the idea that apoceruloplasmin synthesis
continues at a low rate and holoceruloplasmin synthesis is almost
abolished in infants with a copper deficiency.
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Dekaban et al, (.1974] treated four patients with Menkes syndrome.
Case 1 and 2 are the ones they reported on in December of 1974, They
treated both MKHD patients with subcutaneous injection of copper sulfate.
They developed a method for subcutaneous infusion of l-2mg of copper
sulfate in 25-50ml of saline C0.04mg per ml) given by slow infusion or
slow drip over 2 hrs. The clinical response of case 1 was as they
reported, moderately encouraging. The progression of mental deterioration
was at least temporarily arrested, there was a slight improvement in motor
performance and his hair became darker and less friable. Case 2 had spastic
diplegia, seizures and severe retardation. Thus, copper therapy for case
2 was of no value. They concluded that it is particularly important
that MKHD victims be promptly diagnosed and treated in the neonatal stage
of term infants with older brothers who have the disease.
Gamica et al. (1977) suggested a different pathogenetic mechanism
as the underlying cause of MKHD, The hypothesis that they favor is an
abnormality of metallothionein. Metallothionein is a duodenal, renal
and hepatic intracellular transport and storage protein (Dekaban, 1974;
Stemlieb, 1973), This hypothesis is supported by studies in animals
and humans implicating metallothionen in copper storage and absorption
(Van Campen, 1970; Starcher, 1969). Starcher's observations of the
competition between copper and zinc for a presumed duodenal transport
protein suggest that this protein might mediate absorption of both
elements (Starcher, 1969). The molecular weight of this substance
approximates that of metallothionein. Previous hypothesis or the one
presented here could be explained by intestinal malabsorption of copper,
inadequate hepatic storage and utilization, hypocupremia, and a defect
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in metallothionein. One would predict a possible increase in amniotic
fluid copper levels due to elevated fetal urinary copper excretion.
Prenatal diagnosis of Menkes syndrome should therefore be attempted
on this basis.
In 1975 Lott et al. investigated the copper metabolism in an 11
month old male with MKHD Chott, 1975) . Serxam copper was 15iJg per 100ml
and serum ceruloplasmin was undetected. Less than 1% of orally
administered Cu was absorbed. This patient was given supplemental
copper as cupric sulfate in two divided doses totalling 0.52mg per
kilogram per day. Within seven days of such supplemental oral copper
the serum copper rose three-fold (from 15vg per 100ml) and remained at
approximately 75% of the normal concentration for the remaining 22 days
of therapy. After the end of supplementation, the serum copper returned
to baseline in about ten days. It was concluded that the copper
absoirption block is only partial in the Steely-Hair syndrome and is
overcome by high doses of oral supplements.
Lott et al, (1975) suggest that defect in relative absorption of
copper may result from an abnormal complexing of copper within the
intestinal mucosa. When copper is finally released into the blood
stream, an abnormal complex appears associated with albumin and fails
to stimulate ceruloplasmin biosynthesis. They surmised that the
potential therapeutic importance was the finding that persistent high
doses of oral Cu may eventually bypass the block with resultant normal
synthesis or caeruloplasmin.
The therapeutic effects of parenteral copper administration have
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been disappointing (Banks, 1974; Bucknall, 1973), Caeruloplasmin levels
can be restored to normal and liver copper can be replenished. However,
no symptomatic improvement has occurred in patients who were over three
months of age at the start of treatment.
A better result in a baby whose treatment was started at three days
of age was reported by Grover and Scrutton, 1975. Intravenous infusion
of cupric salts was studied in two patients (cousins). The intravenous
doses of copper were gradually increased and normal or near normal serum
values were achieved after ISOyg of Cu per kg were administered daily for
5 days. At that time the hepatic concentration of copper in the two
patients increased from 14 to 38yg per gram of dry weight and from 7 to
45ug per gram of dry weight respectly. Continued infusion of cupric
salts in doses of 190-220pg per kg per day once or twice weekly were
necessary to maintain elevated hepatic and serum concentrations of
copper. At 6 months of age the younger infant had reached a functioning
level of 4 months. The older infant demonstrated progressive loss of
neurologic functions and died at 15 months of age.
The abnormal hair and the low hepatic copper concentration measured
to 3 weeks of age suggest that inadequate copper was stored in fetal
tissue during the latter part of gestation, They did not find any
published information on spontaneous improvement with copper therapy.
They concluded that- their data suggests that early diagnosis by
determining tissue and serum concentrations of copper, and early
institution of therapy to produce rapid elevation of these concentrations
to values within the normal range may influence favorably the progressive
neurologic dysfunction in trichopoliodystrophy.
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In February of 1976 Goka et al, reported the discovery of a
genetic marker in cultured skin fibroblasts from patients diagnosed
with Menkes disease (Goka, 1976>. Their results consistently showed
elevated intracellular concentrations of copper in skin fibroblasts
cultured from patients with Menkes disease. This elevation in copper
concentration set them apart from control subjects that were presumed
heterozygotes. Furthermore, these findings of elevated copper concentra¬
tion on Menkes cultures as a result of the genetic abnormality are
consistent with the reports of Danks et al. (1973a, 1973b). These
observations led them to the conclusion that the increased copper
content of Menkes cells was characteristic of Menkes disease, resulting
from the expression of the genetic abnormality. Thus, this provides
a genetic marker that should prove valuable in both the diagnosis of
Menkes disease and perhaps early detection of Menkes disease. Further¬
more, since it is logical that fetal cells cultured from individuals
with Menkes disease would express the genetic anomaly as increased
copper concentration, prenatal diagnosis may be possible. The marker
was expressed as increased copper concentrations in Menkes cultures.
In December of 1976 Oakes reported the first ultrastructural
study of the thoracic aorta and dermis of an 18 month old body with
Menkes syndrome (Williams, 1977). This boy had been treated in the
year prior to death with intravenous copper. Light microscopy revealed
an absence of distinct elastic laminae in the inner third of the media,
but irregular clumps were present. In the middle and outer media the
elastic laminae was fragmented and discontinuous. The smooth muscle
cells that are normally present between elastic lamellae were replaced
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by sparsely distributed cells with irregular outlines. In many of
these cells large irregular accumulation of metachroraatic material was
seen within the cytoplasm. Also observed was an abnormally large amount
of collagen dispersed in large wavy bundles throughput the wall of the
aorta.
Ultrastructurally, the elastin present was electro-dense and
surrounded by a prominent sheath of microfibrils approximately IIQA in
diameter. A similar observation was made for skin elastic fibers. The
cells of the middle and outer thirds of the aortic wall contained
myofilaments displaced peripherally by large aggregates of flocculent
material. Skin fibroblasts did not contain such aggregates.
They surmised that the abnormal elastic fibers observed in this
child could be explained on the basis of a copper deficiency occurring
very early in life, perhaps even in utero. The abnormally large amount
of collagen present throughout the aortic wall and the sparse cell
population with large cytoplasmic accumulation of metachromatic material
are features not previously described, The collagen probably indicates
a generalized repair response and may in part account for the sparse
cell numbers because of its abundance. However, the nature of the
large intracellular aggregates and thier relationships to copper
deficiency remain imcertain.
In july of 1977, Williams reported his findings dealing with copper
therapy in ^^KHD. In brief, he treated a patient with Menkes’ Kinky Hair
syndrome with oral CUSO4. The results were plasma copper, ceruloplasmin,
red cell copper, and 24 hr urine copper excretion remained essentially
unchanged. Intravenous copper infusion resulted
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in a rise of serum ceruloplasmin. During tKe administration of a test
meal of ^‘^Cu(N03)2, the patient was given alternately a volume of 0,9%
NaCl or an equal volume of plasma intravenously. Radioactivity that
was found in the blood was unchanged after each infusion period. During
427 days of subcutaneous copper, plasma p-phenylenediamine oxidase
activity and plasma copper rose toward normal. Their subsequent
balance studies showed that the patient was in negative copper balance
because of large losses in feces. Also, scanning electron microscopy
demonstrated persistent pili torti. Therefore, they speculated that
Menkes' Kinky Hair S3nidrome is probably due to a generalized defect in
copper-binding protein that results in increased gastrointestinal
copper loss and persistent abnormalities of hair in the copper-depleted
patient.
In August of 1977, Gamica et al, reported their findings after
treating a patient with Menkes' Kinky Hair syndrome. They treated a
4-month old male, with severe neurologic disease. He was treated with
a 3-week course of intravenous cupric acetate. This treatment had to
be discontinued because the infant developed aminoaciduria. Despite
transient increase in serum copper and ceruloplasmin, there was no
change in the progressive CNS deterioration which characterizes this
condition, and, too, the portion of administered copper excreted in the
urine was excessive. Neither serum amine oxidase nor leukocyte cyto¬
chrome oxidase activity varied in a definite relationship with serum
copper. Lastly, the autopsy specimen showed typical pathological change
and low copper concentrations of all tissues examined. These findings
hold true for MKHD. Since intravenous cupric acetate did not
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significantly alter the symptoms associated with Menkes' Kinky Hair
disease, their report questions the value of such treatment,
From their report it seems likely that infants with Kinky Hair
syndrome (KHS) and mice Cmutant alleles at the mottled locus) have a
genetic defect in the intestinal transport of copper. Also, the genetic
lesion in both men and mouse establishes the existence of a specific
transport system for copper. It is also possible, as in the case of the
mottled locus in mice, that multiple alleles at the KHS locus exist in
man. The studies summarized here suggest some of the known defects in
utilization of dietary copper in man.
It was therefore, the purpose of this thesis to determine if a
proper copper therapy could be derived to have a lasting positive




A copper reference solution was purchased from Fisher Scientific
Co. (Atlanta, Georgia). Para-phenylenediamine oxalate was purchased
from Eastman Kodak Co. (Rochester, New York). Bio-Gel P-6Q was
purchased from Bio-RAD Laboratories (Richmond, California). Xanthine,
Xanthine oxidase. Superoxide dismutase, Ceruloplasmine Cytochrome c
from beef heart. Tyrosinase and L-Dopa were purchased from Sigma
Chemical Co. (St. Louis, Missouri). Female mice heterozygous for Mo^^
were obtained from Argonne National Laboratory (Chicago, Illinois).
Animal Care and Diets
Adult mice were maintained on Mouse Chow pellets from Ralston
Purina Company. Regular tap water was used for drinking. All mice
were housed in individual plastic cages with wood shavings as bedding.
All cages were cleaned at least once weekly.
In the control experiments, 6 heterozygous and 6 normal females
of the Mo^^ were maintained on regular mouse chow and tap water. At
birth all pups were counted and the number of pups per litter was
recorded. Starting with the third day at least two pups of each type
were killed by decapitation for analysis.
In the high copper experiments, 6 normal and 6 heterozygous
(Mo^^) females were used. The animals were fed a high copper diet prior
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to insemination and were maintained on this diet. The mature partners
were normal males from the Mo^^ x Black Agouti stock maintained in this
laboratory. Blood copper levels were monitored three times each week
(thrice weekly). The number and type (phenotype) of each litter was
recorded. The pups were sacrificed by decapitation for full copper
and enzymatic analyses of blood, brain and liver.
Tissue Preparation
At indicated postnatal ages, pups of the specified groups were
chosen for samples. The animals were weighed and killed by decapitation.
The brain and liver were immediately removed and placed in ice cold
0.3M sucrose. As much blood as possible was collected and placed in
cold 0.9% NaCl.
The brain was weighed and prepared as follows for cytochrome oxidase
assay. The brain was minced in 3ml of cold MSET (0.25mM mannitol,
0,75mM sucrose, lOmM Tris HCl, ImM EDTA), and homogenized (12 strokes)
in a 5ml Potter-Elvehjem homogenizer fitted with a Teflon pestle. All
preparations were carried out at 0-5°C. The homogenate was centrifuged
at 1500 rpm for 10 min in a JA-20 centrifuge set at 5°C. The super¬
natant solution thus obtained was centrifuged at 15,000 rpm for 3 min,
to give a pellet of crude mitochondria which was resuspended in 1ml of
MSET and used within two hrs for the cytochrome oxidase assay. Part
of the whole homogenate was saved for the tyrosinase assay.
The liver was weighed and prepared as follows for the cytochrome
oxidase assay. The liver was removed from the animal and as much
blood as possible was washed away with ice cold SET (0,25mM sucrose.
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l.QmM EDTA, lOinM Tris HCl). It was then homogenized in 5ml of SET using
10 passes in a 5ml Potter-Elvehjem homogenizer, The whole homogenate
was centrifuged at 15,000 rpms for 3 min, and the supernatant solution
was centrifuged at 15,000 rpms for 5 min (5 C). The pellet thus obtained
was resuspended (with gentle hand homogenization) in 2ml ST and centrifuged
at 15,000 rpms for 5 min. If blood were present in the bottom of the
tube, all of the supernatant and as much of the pellet as possible was
removed without removing any of the blood. This supernatant and pellet
mixture was used to perform enzyme analysis.
The skin was removed (for tyrosinase assay), and treated according
to the method of Brown and Ward (1957) as outlined below. The skin was
frozen immediately and stored at -25 C for between 1 and 7 days before
being used. Tyrosinase activity was stable for at least 12 days. Each
sample was homogenized for 5 min with 5ml of cold (4 C) distilled water
in a 7ml tissue grinder (Coming 7727 tissue grinder). The sample was
then centrifuged with 5ml of cold distilled water and re-centrifuged.
The 2 supernatant fractions were then combined and to them was added 1/10
volume of saturated (^4)280^. A volume of cold (4 C) acetone equal
to that of the supernatant (1^14)2804 mixture was then added and the
precipitation which formed was removed by centrifugation. The
supernatant solution was then centrifuged with an equal volume of cold
acetone, while the pellet was suspended in 5ml of O.lmM phosphate
buffer (pH 6.8) and dialyzed overnight against two changes of cold
distilled water. The dialyzate was then centrifuged and the clear
supernatant solution containing the tyrosinase activity was separated
from the sedimented precipitate and assayed for total tyrosinase activity.
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The blood was prepared for caeruloplasmin and superoxide dismutase
activity as follows; (0.2ml) the blood 0,2ml was placed in 0.9% NaCl,
and centrifuged to separate the supernatant from the red blood cells;
the supernatant was carefully removed and saved for the ceruloplasmin
assay. The supernatant was replaced by an equal voliane of deionized
water, in order to rupture the red blood cell and release the superoxide
dismutase. These two solutions were used for assay within 2 hours after
the sample was obtained.
Cytochrome c Oxidase
The oxidation of reduced cytochrome c was followed at 550nm, 25°C
in 0.1 M pH 7.0 potassium phosphate buffer. Cytochrome c was reduced
with excess ascorbic acid and separated from the reducing agent on a
Bio-Gel P-60 column equilibrated with 0,1 M pH 7.0 potassium phosphate.
The reaction mixture contained O.OlmM reduced cytochrome c in the
0.1 M phosphate buffer and the reaction was initiated by addition of
detergent treated tissue. Initial velocities were used to quantitate
the enzyme. All enzyme assays were carried out using a Beckman Grating
Spectrophotometer Model DB with Beckman Recorder Model 1005,
Cyt c • Fe+ ^ Cyc • Fe^^
Superoxide Dismutase
Superoxide dismutase, a copper-zinc enzyme (also known as cere-
brocuprein; Porter § Folch, 1957) was measured by its ability to inhibit
the reduction of ferricytochrome c by the xanthine oxidase reaction
(McCord S Fridovich, 1969). The red blood cells taken from the decaptitated
mice were used as the source for the superoxide dismutase. The assay
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procedure and definition of units were taken without modification from
McCord § Fridovich (1969). A unit was defined as that amount of original
sample that would cause a 50% inhibition of the rate of reduction of
ferricytochrome c in a final volume of 0.5 ml.
Caeruloplasmin
Determination of caeruloplasmin was carried out by the method of
Curzon and Vallet (1959). Caeruloplasmin oxidizes p-phenylenediamine
and related substances to colored product. The test (serum) samples
were prepared as previously described, 0,01 ml sample was added to 0.5
ml buffer (0.2 M sodium acetate buffer pH 5,5). This mixture was
incubated in a 1 cc curvet at 37 C for 5 min. After incubation
p-phenylenediamine (1.7mM) was added to give a final volume of 1 ml.
The purplish red color was then allowed to develop for 15 min. Readings
were taken at 4, 6, 8 and 10 and 14 minutes and extrapolated to zero
time. All readings were read at 550 mM.
Tyrosinase
The tyrosinase activity, or more accurately the DOPA oxidizing
activity, of the enzyme preparation was determined colorimetrically
as follows: 0.1 M phosphate buffer (pH 6,8) containing 1 mg of L-DOPA,
was held in a water bath at 33 C for 15 min, Aqueous enzyme solution
(usually 0,05 ml) was then added to bring the total volume to 1,0 ml.
This reaction solution was well mixed immediately after addition of the
enzyme solution and its absorbancy was determined every 3^4 min there¬
after at 400nM, The initial rate of increase in absorbancy was found
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to be proportional to the amount of enzyme solution added.
Copper Analysis
Total copper analysis of the blood was carried out as follows:
3 ml of blood was placed in 1 ml of deionized water, and the mixture
was evaluated for its copper content using the Atomic Absorption
Spectrophometer (Perkin Elmer Model 107). Tissue samples were first
ashed in ultra pure nitric acid, diluted to 2 ml with deionized water
and the copper content determined. To avoid copper contamination, all
glassware used in this study was soaked in HNOj for 24 hr and rinsed
in distilled deionized water.
CHAPTER IV
RESULTS
Behavioral and Growth. Effects
Parental copper therapy in both the normal and heterozygous female
led to the survival of only a very few offsprings. The surviving
offsprings included only normal and heterozygous females. The copper
fed mothers became very sluggish and also very canabalistic. As their
blood copper levels approached 100% of normal these symptoms became
more evident and too, several would die close to term or during the
early postpartem period. It was also noted that as blood copper rose
above normal there were fewer offsprings bom to any female. The few
that were bom were usually eaten by the mother.
Subcutaneous copper therapy was administered to male (Mo^^)
offsprings and when they were treated according to the schedule in
Table 1 they did survive. In contrast untreated pups did not survive
beyound 14 days.
Mo^^ males were not significantly smaller than their normal
littermates at birth. Mo^^ males weighed at age 3 days 2.00g 0.08
and normal littermates weighed 2.20g O.lg. A normal weight increase
was noted for all offsprings until about 10 days after birth. After
this time Mo^’^ males started to lose weight and died on the 13th or 14th
day as shown in Fig. lA. As the Mo^^ males approached death there were
periods of general inactivity, and sporadic periods of intense seizure.
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Table 1. Schema of copper injection in normal (Norm) and hemizygous
(Mo^^) male littermates.*
Treated Untreated
Age in days Norm Norm Mo^’^
ul of O.IM CuS04
3 1.0 1.0 0.0 0.0
5 1.0 1.0 0.0 0.0
7 1.0 1.0 0.0 0.0
11 1.0 1.0 0.0 0.0
13 1.0 1.0 0.0 0,0
17 2.0 2.0 0.0 Death
21 2.0 2,0 0.0
2S 2.0 2.0 0.0
28 2.0 2.0 0.0
*The days of injection coincide with the age of the animals.
These animals were examined at different times for blood
copper, tissue copper, and for specific enzymes as stated
elsewhere.
Fig. lA: Growth curve for Mo






males that were treated had a very different inflection of
growth at 12 days (Fig. IB). They had attained about 75% to 85% of
the weight of their normal littermates at 21 days of age. At 28 days of
age, the Mo^^ males usually had attained at least 95% of the weight of
the normal littermates.
There was no observable difference between the general activity of
treated Mo^^ males and normal littermates. The only observable difference
was in coat color (Fig. 2).
Biochemical analysis demonstrated very specific differences between
the normal littermates, lontreated Mo^’^ males and treated Mo^^ males.
The activities of the copper containing enzymes, tyrosinase, ceruloplasmin,
superoxide dismutase and cytochrome oxidase were substantially lower
in untreated Mo^’^ males (Figs. 3a, b, c, d, e). With the exception of
tyrosinase, activities of these same enzymes approached and attained
normal levels in copper treated Mo^^ males (Figs. 3a, b, c, d, e).
Tyrosinase activity remained consistently below normal (Fig. 3e).
Pregnant heterozygous and normal females were fed copper in an
attempt to determine if transplacental copper would result in an
increased level of circulating copper in the pups and possibly contribute
to the prevention of the clinical (phenotypic) aspects of the disease.
It is noteworthy that the copper content of the intestinal vrall of
untreated Mo was 3 times that of normal but after subcutaneous
copper therapy, the copper content of the intestine dropped to normal
levels. This has been a prevalent finding in most of the untreated
Mo animals.
The results of the initial blood copper measurements are presented
Fig. IB: Growth curve for copper treated Mo^’^ males (^)









Fig. 3A: Brain cytochrome c oxidase activity in untreated
Mo^^ males and untreated Mo^’^ males. These









Fig. 3B: Liver cytochrome oxidase activity in xmtreated
Mo^^ males and copper treated Mo^^ males. These
results are expressed as percent of the activity
in normal littermates.
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Fig. 3C: Superoxide dismutase activity in untreated
Mo^^ males and copper treated Mo males.
These results are expressed as percent of






Fig. 3D: Caeruloplasmin activity in untreated Mo^^ males
and copper treated Mo^^ males. These results











Fig. 3E; Tyrosinase activity in untreated Mo^^ males and
bl!!*
copper treated Mo males. These results are







in Table 2. Heterozygous females had blood copper levels slightly
lower than normal. These levels are compared to those of both female
types that were on a high copper diet. The results revealed an increase
in blood copper. It was also noted that the rise in blood copper was
directly related to behavior. This information was presented under the
section titled Growth and Behavior.
The blood copper of normal, untreated Mo^’^ males and treated Mo^’^
male littermates are compared in Table 3. The results show that initially
there was a difference in blood copper between normal and Mo^^ littermates.
The increase in blood copper of Mo^^ males show that blood copper of the
b-r
Mo males can be elevated to normal. V/hen normal littermates were
treated with the same amount of copper as the Mo^^ males there was
either no detectable increase in blood copper or a very slight increase.
IMtreated Mo^^ males have peculiar hair. As shown in Fig. 4 and
Fig. 5, pili torti is evident. Nodules and helical spiraling, curved
hair tips, varying thickness (diameter) of the shaft and nodules are
shown in Figures 6 and 7. The correction of these abnormalities after
copper therapy is seen in Fig. 8. Changes in the coat color are not
evident.
The phenotypic difference between the mice used in these experiments
were distinct. When the heterozygous female (Fig. 9) was about 1 year
of age the coat color was dark brown, and the bands that were present
at 3 weeks of age (Fig. 10) became less distinct as the animal got older.
The untreated hemizygous male (Fig. 11) coat color was different from
both the treated hemizygous male (Fig. 12) and the normal males (Fig. 13),
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Table 2. Blood copper levels in vmtreated and treated heterozygous
females CMo^^l and normal females (Nooti),*
Treated Untreated
Days on
copper diet Norm Norm
0 .075 .073 .075 .073
2 .075 .073 .075 .073
4 .077 .075 ,075 .073
6 .078 .076 .075 .073
8 .083 .080 .075 .073
10 .083 .080 .075 .073
12 .084 .082 .075 .073
14 .085 .085 .075 .073
16 .087 ,085 .075 .073
18 .100 .086 .075 .073
20 .109 .089 .075 .073
21 .150 .100 .075 .073
22 .200 .200 .075 .073
23 .250 .225 ,075 ,073
*Animals were fed a high copper diet as described in methods
section
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Table 3. Blood copper concentration in treated and untreated




1 .013 .013 .013 .013
2 .013 .013 .013 ,013
3 .013 .013 .013 .013
4 .015 .015 ,015 ,013
5 .015 .015 .015 .014
6 .018 .018 .018 .014
7 .029 .025 .029 .014
8 .033 .029 .033 .015
9 .033 .030 .033 .015
10 .035 .032 ,035 .015
11 .036 ,033 ,035 ,015
12 .037 .035 .037 ,015
13 .038 .038 ,038 .015
14 .040 .038 .040 .015
♦Animals were treated with copper as described in methods section.
Fig. 4 Hair with nodule from male (14 days old).
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Fig. 5. Hair showing pili torti from male (14
days old).
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Fig. 6. Hair showing pili torti and nodules from
Mo^’^ male C14 days old).
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Fig. 8 Hair without pili torti from Mo^^ male that
received copper therapy. (14 days old).
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Fig, 9, One year old heterozygous female (Mo^^).
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Fig., IQ. Tliree week old heterozygous female.
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Fig. 11, male 14 days old. untreated.
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Fig. 12. male that received copper therapy (14 days
old).
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Fig. 13, Normal male C14 days old),
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The normal mouse, male or female (pig. 14), had a black coat and did
not have the hair abnormalities that are characteristic of the untreated
hemizygous male. Hair abnormalities such as curved hair tips CFig- 15)
and pili torti (Fig. 5) were only present in untreated hemizygous males.
Estimates of liver, brain, and intestinal wall copper are listed
in Table 4. The presence of low copper levels in brain and liver
confirm the presence of copper deficiency in Mo^’^ males. The
accumulation of copper in the intestinal wall indicate that there
is a malabsorption defect. However in treated Mo^^ males, the copper
level in the intestinal wall was restored to normal.
Fig. 14. One year old normal female.
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Table 4, Copper levels in liver and brain tissue of normal (Norm),
and, treated and untreated hemizygous males (Wo^^),*
Copper levels in brain, liver, and intestinal wall of 14 day
old normal (Norm), brindle (Mo^^), and treated brindle CMo^^)








Brain 2.43 1.43 2.43 41.10
Liver 24.23 9.37 24.23 64.20
Intestinal 4.39 10.13 4.39 130.20
Wall
*The tissues were sampled at 10 days postnatally.
CHAPTER V
DISCUSSION
In our experiments the heterozygote brindle variant female was fed
copper in an attempt to normalize the hemizygous male offspring, but
when the plasma copper level approached or exceeded 100% of normal the
mothers did not survive. Plasma copper levels lower than 100% of normal
had no effect on the hemizygous male offspring. Because of this
difficulty, all further attempts to normalize the hemizygous males by
elevating the mothers blood copper was abandoned. All subsequent
attempts were directed towards the male hemizygous offspring itself.
The data presented here show the effect of copper therapy on the
survival of the affected male offspring (Mo^^). When copper therapy
was administered subcutaneously, there was a rise in whole blood
copper. During the treatment period there was a rise in the activity
of the four enzymes evaluated. The growth curve of the affected
animal reached at least 97% that of the normal.
males are not significantly smaller than their normal litter-
mates at birth (Fig. la). They increase in weight normally until about
10 days after birth. At this time there is a cessation of growth. They
lose weight and death usually follows on day 13 or 14.
br
In contrast, the copper treated Mo males are not significantly
smaller than their normal littermates (Fig. lb). TTiere was never a
difference in body weight of more than 15% between the treated defective
mouse and the normal one. Treated Mo^^ males live as long as their normal
littermates. The normalization of the life span occurred only when they
58
59
were treated as in Table 1, This is probably due mainly to the increased
activity of cytochrome oxidase.
Data on blood and other tissue levels of copper (Table 4) in normal,
Mo^^, and copper treated Mo^’^ animals could be indicative of a homeostatic
control of blood copper levels, which could be explained as follows:
It would be physiologically wise to have a mechanism designed to maintain
a relatively constant blood copper level, which involves transport from
the G.I. (gastro-intestinal) system to the blood, extraction by tissues
and excretion via the renal system. A lack of this control can result
in Wilson’s disease. On the other hand, if this control is functioning,
but the intended supply source is reduced, then tissue stores would
become auxiliary pools, the extraction value would be negative, and
bi!*
tissues would then become depleted. The blood levels in untreated Mo
males would stay therefore at the new bom (day 1) level Cwhich is
identical to the levels of the normal 1 day littermate) and never
bT*
increase. Blood copper and other tissue levels of the treated Mo
males minanic those of the untreated normal (Table 2 and Table 3), and
indicate that the adequate availability of circulating copper, facilitates
the uptake by, and maintenance of adequate tissue copper.
Cytochrome oxidase activity was consistently lower in untreated Mo^^
males when compared to normal littermates (Figs. 3a, 3b). The activity
of cytochrome oxidase decreased as the animals approached 14 days of age.
In the copper treated Mo^^ males, however, the cytochrome oxidase
activity never differed more than 10% from the activity observed
in normal littermates CFigs, 3a, 3b) , This finding does not differ
substantially from the earlier finding by French et al. (1972); however
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it is now clear that the reason for the decrease in cytochrome oxidase
activity was not due to a simple defect in cytochrome oxidase, but more
likely a decrease in synthesis or an increase in degradation. If it
were true that there were an abnormal oxidase then one might not expect
an increase in the enzymatic activity of cytochrome oxidase when copper
was made available to the organism unless the defective apoprotein could
be activated by copper. It can be agreed upon, however, that the need
for copper might alter the rate of enzyme synthesis and or the chemistry
of the protein synthesized. After reviewing these results our hypothesis
is that apocytochrome oxidase is synthesized as a complete structure and
that copper insertion into at least one of the polypeptide chains is
required for activation. The incomplete studies of Schiefer (1969) on
the biosynthesis of cytochrome oxidase indicate a possible order for the
insertion of hemes, copper and lipids into the various polypeptides which
make up the apoenzyme. It was also reported by Winter et al. (1978)
that copper is specifically attached to one and probably two of the
seven polypeptides of beef heart cytochrome oxidase. Our hypothesis
is further supported by the fact that when the copper treatment was
discontinued at approximately the fifteenth day postnatally, the brain
cytochrome oxidase levels again decreased to a critical level and the
animals died. This indicates that the copper levels are too low for
adequate cytochrome oxidase synthesis or activity, and energy production
would thus be limited and death would ensue. Immunologic studies are
being pursued by our laboratory to clarify the question of whether
there is de novo synthesis of cytochrome oxidase upon copper therapy,
or whether the apoenzyme is present at an approximately normal level.
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The level of siq)eroxide dismutase was significantly raised to
within 10% of normal (Fig. 3c) . When Mo^^ males were treated as
indicated, superoxide dismutase activity never fell below the 80% level
of the normal littermates. This information could also be explained
by the hypothesis that superoxide dismutase is synthesized as an
apoprotein and copper is bound to it (during or after synthesis) for
activation. Again immunochemical methods are planned for identification
of the apo-siqjeroxide dismutase to validate our hypothesis.
Caeruloplasmin in Mo^^^ males was the most responsive of the four
enzymes evaluated. In the Mo^^ males that were not treated with copper,
the caeruloplasmin level dropped sharply as the animal approached death
(Fig. 3d), But, in the Mo^^ males that received copper therapy, caerulo¬
plasmin levels remained within 80% of the level found in normal litter¬
mates. Since we do know that the mottled mouse syndrome is one of
copper malabsorption and since the level of caeruloplasmin was restored
by bypassing the intestinal transport system it is possible that
caeruloplasmin could be synthesized as an apoenzyme in the absence of
copper. With the rise in plasma copper the liver could then insert
copper into apo-caeruloplasmin to form the holo-caeruloplasmin. This
statement is also supported by the fact, that when plasma copper is
barely detectable the plasma caeruloplasmin is also barely detectable.
The statement on the insertion of copper post-translationally can be
supported by the studies of Levine and French (1965), They demonstrated
the removal and reinsertion of copper into purified caeruloplasmin.
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The decreased or absent haix pigmentation in Mo males is consistent
with that observed in human MKHD patients, The tyrosinase activity was
the least affected enzyme in response to copper therapy CFigs. 3e, 12).
Tyrosinase activity was undetectable in untreated Mo^’^ males. While, at
the same time the activity in treated Mo^^ males was 75 to 85% of the
activity found in normal littermates. This finding was expected. The
fact that coat color did not totally return to normal is possibly an
expression of the decrease of tyrosinase activity. Although coat
color did not return to normal there were other positive effects of
copper therapy on the hair. For example, hair structure was greatly
affected in Mo^^ males that received copper therapy. In Fig. 4 and Fig.
5, pili torti is seen in Mo^^ males that did not receive copper therapy,
t-
but pili torti is not found in Mo° males that received copper therapy.
Other abnormalities of the hair that were found in untreated Mo^^ males
and were not found in males that received copper therapy included
the occurrence of nodules (Fig. 6), curved hair tips (Fig. 14), and
varying diameter of the hair shaft (which is responsible for the axial
twisting) Fig. 7. The explanation for the normalization of these
features and not the coat color can best be derived from the apparent
time coordinates of coat color development in the heterozygous females.
When the heterozygous female is about 3 to 4 weeks of age the coat
color is very distinct in its very light brown patterns (Fig- 10), but,
as the animals get older the pattern of brown bands in the coat color
becomes less distinct. After about one year, the heterozygous female
coat color has become so dark brown that it is often difficult to
determine whether the animal is black (normal female) or ash-brown
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(heterozygous female) in color (Fig. 9). This gradual increase in coat
color could be indicative of the net accumulative nature of the tyrosinase.
It is possible that synthesis of tyrosinase may be slow but constant and
its destruction much slower. Hie kinetics of destruction could be based
on a high Km of the proteases for tyrosinase.
Low liver and brain copper levels were found in all untreated Mo^^
males after the first day of age (Table 4), However, at birth and
during the first week of life, no difference in vascular and nonvascular
tissue copper levels was fotind. This is because Mo^^ males have
adequate copper stores at birth, as clinical manifestations do not
appear for 2 or 3 days (absence of color). It is likely that reduction
or abolition of copper stores in these Mo^^ males would result in their
becoming fatally copper depleted by the end of two weeks as stated
above. The 14 day interval seems to be independent of the size of the
animal and dependent on the size of the pool of copper stores at birth.
However, once symptoms appear, i.e. the onset of seizures and clinical
deterioration, as reported here, the animal is irretrievable and death
usually follows.
The data in Table 3 suggest that a homeostatic mechanism is
operative by which the blood copper levels do not drop below a certain
perinatal level. The copper will be derived from existing stores
unless dietary siq)ply of copper leads to an appropriate increase. Since
the diet cannot supply copper, then the indication is that non-vascular
cellular copper may drop to maintain these low circulating levels as is
the case with bone dissoultion when Csr or phosphate levels are low.
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The major thexapeutic implication presented her is that the clinical
manifestation of MKHD can be prevented in the mottled mutant mouse (Mo^^),
Obviously, the next step is whether or not the findings presented here
are relevant to and can be applied to the human disorder. The major
implication is the time table of treatment vs. the clinical manifestation
of Menkes Kinky Hair Syndrome. Once the clinical symptoms appear it is
already too late to reverse the effect of MKHD. Therefore, a new and
probably better course of treatment must be suggested.
Although intrauterine diagnosis seems unlikely because the infant
will be receiving adequate copper from his mother, there are data which
indicate that amniotic cells obtained by amniocentesis show aberrant
copper accumulation. Menkes suggested in 1973 that when there is a
family history of a death of a child from Menkes' syndrome, sexing in
early pregnancy is important when the fetus is found to be male an
abortion could be advised. He also suggested that early parenteral
copper therapy might be successful in preventing cerebral damage.
The finding presented here neither supports nor implicates such treatment
as a possible cure or long term treatment.
The implications of our findings suggest that intrauterine diagnosis
is possible, and treatment should begin prenatally at best, or should
be started at least 48 hr after birth, The therapy should be administered
to all males bom into such families with histories of MKHD. After a
relative short period the infant should be able to absorb copper from
his diet. This hypothesis is supported by the fact that the Mo^’^ males
can survive without copper supplementation after receiving copper therapy
for only 4 weeks and too that in the baby reported on in Philadelphia's
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Childrens Hospital, copper levels remained normal after cessation of
intravenous or intramuscular copper therapy at age 18 months approximately
(personal communication).
A possible explanation for the survival of the Mo^^ males after the
short term copper therapy would be that the ability to bypass the
affected intestinal cells made copper available to all tissues and, too,
that in this disorder, there is a secondary recovery of the intestinal
mucosal cells, so that copper can eventually be obtained from the diet
in adequate amounts. Experimental and therapeutic timing must be
crucial since the development of the mouse brain is vastly different
from that of the hiunan. Development of the mouse brain is crucial and
occurs to the greatest extent up to the 14th or 15th day postnatally.
If the brain can survive then the chances of normalization of the animal
are enhanced, and that is what our data indicate.
CHAPTER VI
SUMMARY AND CONCLUSION
Himt (1974) has described variants of the mottled mutant mouse
(Mo) with different degrees of abnormality relative to malabsorption
of copper. The brindled variant (Mo^^) was used to study the problem
of copper nutrition as a model for Menkes Kinky Hair disease. This
X-linked inherited progressive brain disease is invariably fatal with
focal cerebellar and cerebral degeneration, growth retardation and
abnormal hair. Recurrent convulsions are prevalent as the disease
progresses. Addition of 1 to 200mM copper sulfate to the drinking
water caused a high degree of fatality as did addition of copper to
the mouse chow. Subcutaneously injected copper did lead to the
survival of the Mo^’^ males.
Among the enzymes most directly affected is brain mitochondrial
cytochrome oxidase. Since this enzyme is essential for respiration
and oxidative phosphorylation, it is noteworthy that the amount of
the spectrophometrically measurable enzyme decreases from birth to
when the animal dies at about 14 days, of age.
In brain mitochondria of 2-4 day old animals, the ratio of the
amount of cytochrome oxidase in the affected animals to that in the
normal controls is 0.48; by 6-8 days of age, it is 0.43; and by 11-14
days of age, it is only 0.14. Other studies emphasize the importance
of copper as an integral part of cytochrome a+a5 in brain and suggests
that depletion of cytochrome oxidase in the mouse and in victims of
the human genetic disease, Menkes Kinky Hair syndrome, may be related
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to the retardation and death caused by these diseases.
Although subcutaneously injected copper did lead to the survival
of the hemizygous males, the age of the animal and the initiation of
copper therapy seemed to have a very precise synchrony.
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